A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects
Clinical trial NCT00215852 · TERMINATED
Trial details
- NCT number
- NCT00215852
- Sponsor
- AIM ImmunoTech Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2009-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.